Senores Pharmaceuticals has entered into the Share Purchase agreement (SPA) with certain shareholders (Public Category) of Havix Group Inc. D/B/A Aavis Pharmaceuticals (Havix) for acquisition of 8454 equity shares of Havix aggregating to 3.73% of the total paid up share capital of Havix and subject to the terms and conditions as mentioned in the SPA.
Further, post the aforesaid acquisition, the shareholding of the Company in Havix will increase from 51.23% to 54.96%. The said acquisition will be completed within the period of 10 days from the date of execution of SPA.
Senores Pharmaceuticals is global research driven pharmaceutical company engaged in developing and manufacturing a wide range of generic pharmaceutical products in the B2B segment predominantly for the Regulated Markets across various therapeutic areas and dosage forms.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1786.85 |
Dr. Reddys Lab | 1173.55 |
Cipla | 1525.50 |
Lupin | 2018.35 |
Zydus Lifesciences | 859.10 |
View more.. |